NCT02020707 - Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 24, 2014

Primary Completion Date

July 18, 2024

Study Completion Date

July 18, 2024

Conditions

Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous CarcinomaCervical CarcinosarcomaCervical Squamous Cell CarcinomaClinical Stage IV Cutaneous Melanoma AJCC v8Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Mucinous AdenocarcinomaEndometrial Serous AdenocarcinomaEndometrial Undifferentiated CarcinomaFallopian Tube AdenocarcinomaFallopian Tube CarcinosarcomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous AdenocarcinomaFallopian Tube Squamous Cell CarcinomaFallopian Tube Transitional Cell CarcinomaFallopian Tube Undifferentiated CarcinomaMalignant Female Reproductive System NeoplasmMalignant Ovarian Clear Cell TumorMalignant Ovarian Endometrioid TumorMalignant Ovarian Epithelial TumorMalignant Ovarian Mucinous TumorMalignant Peritoneal NeoplasmMalignant Solid NeoplasmOvarian CarcinosarcomaOvarian Clear Cell AdenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian High Grade Serous AdenocarcinomaOvarian Mucinous AdenocarcinomaOvarian Serous AdenocarcinomaOvarian Transitional Cell CarcinomaOvarian Undifferentiated CarcinomaPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal CarcinomaPlatinum-Sensitive Ovarian CarcinomaPrimary Peritoneal CarcinosarcomaPrimary Peritoneal Clear Cell AdenocarcinomaPrimary Peritoneal Serous AdenocarcinomaPrimary Peritoneal Transitional Cell CarcinomaPrimary Peritoneal Undifferentiated CarcinomaUnresectable MelanomaUterine Corpus Carcinosarcoma

Interventions

BIOLOGICAL

Bevacizumab

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Nab-paclitaxel

Given IV

OTHER

Pharmacological Study

Correlative studies

Trial Locations (4)

55905

Mayo Clinic in Rochester, Rochester

85054

Mayo Clinic Hospital in Arizona, Phoenix

85259

Mayo Clinic in Arizona, Scottsdale

32224-9980

Mayo Clinic in Florida, Jacksonville